SEC Form 4 · accession 0001225208-17-009615
Merck & Co., Inc. · MRK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
C Robert Kidder
Director
Period of report
May 12, 2017
Accepted (ET)
May 12, 2017 · 4:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000310158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 12, 2017 | M | 5,000 | $35.19 | A | 14,317 | D | |
| Common Stock | May 12, 2017 | S | 5,000 | $63.539 | D | 9,317 | D | |
| Common Stock | holding | — | — | — | 1,022 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $35.19 | May 12, 2017 | M | 5,000 | D | Aug 4, 2011 | Aug 3, 2020 | Common Stock | 5,000 | 0 | D |
Explanation of responses
- F1The option became exercisable in equal installments on 8/4/2011, 8/4/2012 and 8/4/2013.